---
document_datetime: 2023-09-21 19:06:02
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/lojuxta-epar-all-authorised-presentations_en.pdf
document_name: lojuxta-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0573775
conversion_datetime: 2025-12-24 05:15:36.669503
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA(EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Pack size   |
|-----------------|-------------------|------------|-----------------------|---------------------------|-----------------------|-------------|
| EU/1/13/851/001 | Lojuxta           | 5 mg       | Capsule, hard         | Oral use                  | bottle (HDPE)         | 28 capsules |
| EU/1/13/851/002 | Lojuxta           | 10 mg      | Capsule, hard         | Oral use                  | bottle (HDPE)         | 28 capsules |
| EU/1/13/851/003 | Lojuxta           | 20 mg      | Capsule, hard         | Oral use                  | bottle (HDPE)         | 28 capsules |
| EU/1/13/851/004 | Lojuxta           | 30 mg      | Capsule, hard         | Oral use                  | bottle (HDPE)         | 28 capsules |
| EU/1/13/851/005 | Lojuxta           | 40 mg      | Capsule, hard         | Oral use                  | bottle (HDPE)         | 28 capsules |
| EU/1/13/851/006 | Lojuxta           | 60 mg      | Capsule, hard         | Oral use                  | bottle (HDPE)         | 28 capsules |